Bio


Dr. Ann Ming Yeh is an Clinical Associate Professor at Stanford University in Pediatric Gastroenterology and practices at Lucile Packard Children’s Hospital and California Pacific Medical Center. She obtained her Bachelor of Arts degree at University of Pennsylvania with a focus in Biological Basis of Behavior and Chinese. She completed her medical training at Albert Einstein College of Medicine in New York. She then moved to the San Francisco Bay Area for her pediatric residency and gastroenterology fellowship at Stanford. She is board certified in Pediatrics and Pediatric Gastroenterology

Dr. Yeh’s research interests include inflammatory bowel disease, nutrition, and integrative medicine for pediatric gastroenterology. She has presented her research on fatty liver, inflammatory bowel disease and integrative medicine at national meetings.

She completed a two-year distance learning fellowship through the University of Arizona’s Center for Integrative Medicine where she gained additional expertise in mind-body therapies, botanicals, and nutritional supplements. With skill and compassion, Dr. Yeh treats her patients with a comprehensive, evidence-based, holistic approach.She is also a formally trained and board certified medical acupuncturist, she has studied the efficacy of acupuncture for functional GI disorders and on chemotherapy-induced nausea and vomiting.

Outside of medicine, she enjoys yoga, gardening, hiking, and traveling with her family.

Clinical Focus


  • Pediatric Gastroenterology
  • Integrative Medicine
  • Inflammatory Bowel Diseases
  • Child Nutrition Disorders

Academic Appointments


Honors & Awards


  • Bechtel Fellow in Pediatric Translational Medicine Research Award, Lucile Packard Children's Hospital (June 2012)

Boards, Advisory Committees, Professional Organizations


  • member, NASPGHAN (2010 - Present)

Professional Education


  • Board Certification: Acupuncture, American Board of Medical Acupuncture
  • Fellowship:University of Arizona - Center for Integrative MedicineAZ
  • Fellowship:Stanford University School of Medicine (2011) CA
  • Board Certification: Pediatric Gastroenterology, American Board of Pediatrics (2013)
  • Residency:Stanford University School of Medicine (2009) CA
  • Board Certification, American Board of Pediatrics, Gastroenterology, Pediatric Gastroenterology (2013)
  • Professional Education:Helms Medical Institute (2010) CA
  • Board Certification: Pediatrics, American Board of Pediatrics (2009)
  • Medical Education:Albert Einstein College of Medicine (2006) NY

All Publications


  • Spanish and English Language Symposia to Enhance Activation in Pediatric Inflammatory Bowel Disease. Journal of pediatric gastroenterology and nutrition Martin, M., Garcia, M., Christofferson, M., Bensen, R., Yeh, A. M., Park, K. T. 2016; 63 (5): 508-511

    Abstract

    Patient activation is an important consideration for improved health outcomes in the management of chronic diseases. Limited English proficiency (LEP) among patients and primary care providers has been shown to be a predictor for worse health across disease states. We aimed to determine the baseline patient activation measure (PAM) among Spanish-speaking (SP) and English-speaking (ES) pediatric IBD patients and parents, and to describe the feasibility and efficacy of a novel peer-group education symposium designed to enhance patient activation as measured with the PAM.Two separate half-day educational symposia in either Spanish or English were presented and moderated by 2 native Spanish-speaking physicians. Content for each of the presentations were highly standardized and interactive, designed to address each of the activation domains (self-management, collaboration with a health care provider, maintenance of function and prevention of disease exacerbation, and appropriate access to high-quality care). Descriptive statistics were used to describe changes between pre- and post-symposium PAM trends.11 primarily SP and 21 ES families participated in their respective symposium. Paired pre- and post-PAM scores were available from 24 pediatric IBD patients (8 SP; 16 ES) and 41 parents (15 SP; 26 ES). The mean age for SP and ES patients was 11.6 and 12.0 years, and female gender in 80% and 62%, respectively. Paired pre- and post-PAM scores for all participants (n = 65) were analyzed. PAM scores uniformly increased in all 4 groups after the symposia (SP-patients 59.1 to 70.3, P = 0.05; SP-parents 69.8 to 75.2, P = 0.2; ES-patients 59.9 to 64.0, P = 0.08; ES-parents 61.9 to 69.1, P = 0.002), although only the ES-parents group had sufficient sample size (n = 26) to achieve statistical significance. The overall cohort had an aggregate increase from pre-PAM of 62.9 (SD 14.5) to post-PAM of 69.4 (SD 13.9) (<0.001).We describe a novel peer-group educational symposium presented in Spanish and English languages to increase patient and parent activation in pediatric IBD patients and their care-giving parents. The use of PAM to assess levels of activation appears to be feasible and effective in these groups.

    View details for PubMedID 27031374

  • Bugs and Guts: Practical Applications of Probiotics for Gastrointestinal Disorders in Children NUTRITION IN CLINICAL PRACTICE Barnes, D., Yeh, A. M. 2015; 30 (6): 747-759

    View details for DOI 10.1177/0884533615610081

    View details for Web of Science ID 000364637500003

    View details for PubMedID 26538058

  • Integrative Treatment of Reflux and Functional Dyspepsia in Children. Children (Basel, Switzerland) Yeh, A. M., Golianu, B. 2014; 1 (2): 119-133

    Abstract

    Gastroesophageal reflux disease (GERD) and functional dyspepsia (FD) are common problems in the pediatric population, with up to 7% of school-age children and up to 8% of adolescents suffering from epigastric pain, heartburn, and regurgitation. Reflux is defined as the passage of stomach contents into the esophagus, while GERD refers to reflux symptoms that are associated with symptoms or complications-such as pain, asthma, aspiration pneumonia, or chronic cough. FD, as defined by the Rome III classification, is a persistent upper abdominal pain or discomfort, not related to bowel movements, and without any organic cause, that is present for at least two months prior to diagnosis. Endoscopic examination is typically negative in FD, whereas patients with GERD may have evidence of esophagitis or gastritis either grossly or microscopically. Up to 70% of children with dyspepsia exhibit delayed gastric emptying. Treatment of GERD and FD requires an integrative approach that may include pharmacologic therapy, treating concurrent constipation, botanicals, mind body techniques, improving sleep hygiene, increasing physical activity, and traditional Chinese medicine and acupuncture.

    View details for DOI 10.3390/children1020119

    View details for PubMedID 27417471

    View details for PubMedCentralID PMC4928719

  • Acupuncture for Pediatric Pain. Children (Basel, Switzerland) Golianu, B., Yeh, A. M., Brooks, M. 2014; 1 (2): 134-148

    Abstract

    Chronic pain is a growing problem in children, with prevalence as high as 30.8%. Acupuncture has been found to be useful in many chronic pain conditions, and may be of clinical value in a multidisciplinary treatment program. The basic principles of acupuncture are reviewed, as well as studies exploring basic mechanisms of acupuncture and clinical efficacy. Conditions commonly treated in the pediatric pain clinic, including headache, abdominal pain, fibromyalgia, juvenile arthritis, complex regional pain syndrome, cancer pain, as well as perioperative pain studies are reviewed and discussed. Areas in need of further research are identified, and procedural aspects of acupuncture practice and safety studies are reviewed. Acupuncture can be an effective adjuvant in the care of pediatric patients with painful conditions, both in a chronic and an acute setting. Further studies, including randomized controlled trials, as well as trials of comparative effectiveness are needed.

    View details for DOI 10.3390/children1020134

    View details for PubMedID 27417472

    View details for PubMedCentralID PMC4928723

  • Infliximab for the treatment of granulomatous peritonitis. Digestive diseases and sciences Yeh, A. M., Kerner, J., Hillard, P., Bass, D. 2013; 58 (12): 3397-3399

    View details for DOI 10.1007/s10620-013-2726-6

    View details for PubMedID 23817923

  • Acute Liver Failure and Aplastic Anemia in an 11-Year-Old Girl DIGESTIVE DISEASES AND SCIENCES Yeh, A. M., Mojtahed, A., Bass, D. 2011; 56 (8): 2237-2240

    View details for DOI 10.1007/s10620-011-1678-y

    View details for Web of Science ID 000293296100006

    View details for PubMedID 21442323